Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood

Figure 2

Oligosaccharide analysis of the anti-CD20 IgG1 rituximab variants. a Each value of composition is the relative amount in total complex-type oligosaccharides detected. b Schematic descriptions of oligosaccharides correspond to: galactose (triangle), N-acetylglucosamine (GlcNAc) (circle), mannose (square), and core fucose (star). c Relative amount of non-fucosylated oligosaccharides. d Data from reference 28. e n.d.: not detected (less than 2.0%).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us